A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors

Clinical trial NCT05602792 · UNKNOWN

Trial details

NCT number: NCT05602792
Sponsor: ImmVira Pharma Co. Ltd
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor Sarcoma HNSCC Breast Cancer Esophagus Cancer NSCLC Non-melanoma Skin Cancer

Start date: 2020-04-21
Primary completion: 2023-07-01
Enrollment: 233

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.